Announced Mon, 19 May · 15:14 IST

Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sunil Healthcare Ltd has informed BSE that its Board of Directors will meet on May 29, 2025 via video conferencing. The main agenda is to consider and approve the audited financial results (both standalone and consolidated) for the fourth quarter of FY 2024-25 and for the full financial year ended March 31, 2025. The trading window for insiders remains closed from April 1, 2025 to May 31, 2025 in line with insider trading regulations. No financial figures or specific outcomes have been disclosed in this intimation, which is a standard procedural filing ahead of the results announcement.

Likely market impact

This is a routine compliance filing and has no direct impact on the stock price. Investors should watch for the actual financial results to be published after the May 29 board meeting to assess the company's FY25 performance.